CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3

Phase 3ARCALYSTKPL-387Positive
AI Analysis

Summary

Kiniksa reported growth in ARCALYST and announced that KPL-387 is advancing into Phase 3 clinical trials.

Clinical Trial Data

Phase

Phase 3

Outcome Details

KPL-387 advances into Phase 3

Importance:6/10
Sentiment:
0.60
drug_developmentclinical_trialPhase_3ARCALYSTKPL-387
Related Companies

Read the original article

Published by yahoo_finance on August 15, 2026 1:01 AM

Read Original